BG93979A - Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им - Google Patents

Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им

Info

Publication number
BG93979A
BG93979A BG093979A BG9397991A BG93979A BG 93979 A BG93979 A BG 93979A BG 093979 A BG093979 A BG 093979A BG 9397991 A BG9397991 A BG 9397991A BG 93979 A BG93979 A BG 93979A
Authority
BG
Bulgaria
Prior art keywords
derivatives
dihydrobenzofuran
benzopyran
piperidinyl
dihydro
Prior art date
Application number
BG093979A
Other languages
English (en)
Other versions
BG60381B1 (bg
Inventor
Georges Henri Paul Daele
Jean-Paul Bosmans
Michel Anna Jozef Cleyn
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BG93979A publication Critical patent/BG93979A/bg
Publication of BG60381B1 publication Critical patent/BG60381B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Съединенията стимулират перисталтиката на стомашно-чревния тракт. Те имат формула в която а е радикал с формула -сн2-сн2-, -сн2-сн2-сн2или -сн2-сн2-сн2-сн2-, като един или два водородни атома в тези радикали могат да бъдат заместени с с1-6алкилов радикал; r1 е хало, r2 е водород, амино, моноили ди(с1-6алкил)амино или с1-6 алкилкарбониламино; r3 е водород или с1-6алкил; l е с3-6циклоалкил, с5-6циклоалканон, с3-6алкенил, незадължително заместен с арил, или l е радикал с формула -аiк-r4, -аiк-х-r5, -аiк-y-с(=0)-r7 или -аiк-y-с(=0)-nr9r10. Изобретението се отнася и до техните n-оксидни форми, до присъединителните им соли и стереохимичните им изомерни форми, до фармацевтичните състави, включващи като активно вещество тези съединения, а също така и до метод за получаването им. 13 претенции
BG93979A 1990-03-06 1991-03-05 Производни на n-(4-пиперидинил)(дихидробензофуранили дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им BG60381B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909005014A GB9005014D0 (en) 1990-03-06 1990-03-06 N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives

Publications (2)

Publication Number Publication Date
BG93979A true BG93979A (bg) 1993-12-24
BG60381B1 BG60381B1 (bg) 1995-01-31

Family

ID=10672103

Family Applications (1)

Application Number Title Priority Date Filing Date
BG93979A BG60381B1 (bg) 1990-03-06 1991-03-05 Производни на n-(4-пиперидинил)(дихидробензофуранили дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им

Country Status (39)

Country Link
US (2) US5185335A (bg)
EP (1) EP0445862B1 (bg)
JP (1) JP2601566B2 (bg)
KR (1) KR0177521B1 (bg)
CN (1) CN1038936C (bg)
AT (1) ATE191912T1 (bg)
AU (1) AU636012B2 (bg)
BG (1) BG60381B1 (bg)
CA (1) CA2037575C (bg)
CY (1) CY2235B1 (bg)
CZ (1) CZ286617B6 (bg)
DE (1) DE69132119T2 (bg)
DK (1) DK0445862T3 (bg)
ES (1) ES2147175T3 (bg)
FI (1) FI101622B1 (bg)
GB (1) GB9005014D0 (bg)
GR (1) GR3033461T3 (bg)
HK (1) HK1010727A1 (bg)
HR (1) HRP930483B1 (bg)
HU (2) HU221627B1 (bg)
IE (1) IE910710A1 (bg)
IL (1) IL97018A (bg)
LT (1) LT3708B (bg)
LV (1) LV10085B (bg)
MA (1) MA22076A1 (bg)
MY (1) MY108831A (bg)
NO (1) NO177424C (bg)
NZ (1) NZ237189A (bg)
PL (6) PL168384B1 (bg)
PT (1) PT96937B (bg)
RU (1) RU2070884C1 (bg)
SG (1) SG47482A1 (bg)
SI (1) SI9110396B (bg)
SK (2) SK282406B6 (bg)
TN (1) TNSN91010A1 (bg)
UA (1) UA25969A1 (bg)
YU (1) YU48854B (bg)
ZA (1) ZA911611B (bg)
ZW (1) ZW2391A1 (bg)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674849B1 (fr) * 1991-04-02 1994-12-23 Logeais Labor Jacques Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
EP0604494B1 (en) * 1991-09-12 1999-07-28 Smithkline Beecham Plc 5-ht4 receptor antagonists
JPH07503480A (ja) * 1992-02-06 1995-04-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４拮抗薬としてのベンゾピラン，ベンゾチオピランおよびベンゾフラン誘導体
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
US5708174A (en) * 1992-03-12 1998-01-13 Smithkline Beecham P.L.C. Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists
GB9219163D0 (en) * 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
TW294595B (bg) * 1992-11-20 1997-01-01 Janssen Pharmaceutica Nv
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
JPH0820586A (ja) 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
JPH0873463A (ja) 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
KR100388255B1 (ko) * 1994-09-27 2003-10-04 얀센 파마슈티카 엔.브이. 페닐-옥소-알킬-(4-피페리디닐)벤조에이트유도체
DE69513846T2 (de) * 1994-09-27 2000-07-06 Janssen Pharmaceutica N.V., Beerse N-substituierte piperidinyl bicyclische benzoatderivate
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
GB9507882D0 (en) * 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
TW402591B (en) 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
ES2234248T3 (es) 1998-04-28 2005-06-16 Dainippon Pharmaceutical Co., Ltd. Derivados de 1-(1-sustituido-4-piperidinil) metil)-4-piperidina, procedimiento de produccion de estos; composiciones medicinales que contienen estos compuestos e intermediarios de estos compuestos.
CA2332275A1 (en) * 1998-05-14 1999-11-18 Zoltan Tamas Nagy Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
DE69935600T2 (de) * 1998-09-10 2007-12-06 F. Hoffmann-La Roche Ag Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten
EP1135130A1 (en) * 1998-11-23 2001-09-26 Janssen Pharmaceutica N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
JO2181B1 (en) * 1999-04-29 2003-04-23 شركة جانسين فارماسوتيكا ان. في Procalopride solution is taken by mouth
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
GB0011838D0 (en) * 2000-05-17 2000-07-05 Astrazeneca Ab Chemical compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
ATE295845T1 (de) * 2002-01-16 2005-06-15 Janssen Pharmaceutica Nv Prucaloprid-n-oxid
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
DE10349113A1 (de) * 2003-10-17 2005-05-12 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Aminocrotonylverbindungen
GB0525661D0 (en) * 2005-12-16 2006-01-25 Glaxo Group Ltd Novel compounds
RU2451018C2 (ru) * 2006-04-07 2012-05-20 Вертекс Фармасьютикалз Инкорпорейтед Модуляторы атф-связывающих кассетных транспортеров
CN102477002B (zh) * 2010-11-26 2015-04-15 苏州凯达生物医药技术有限公司 3-氨基-2,2-双甲基丙酰胺的制备方法
EP2678332B1 (en) 2011-02-25 2016-05-18 Yuhan Corporation Diaminopyrimidine derivatives and processes for the preparation thereof
GB201103397D0 (bg) * 2011-02-28 2011-04-13 Shire Movetis N V
KR101256908B1 (ko) 2011-04-28 2013-04-23 (주)에이치비메디컬스 주름제거용 충전체
CN102295594B (zh) * 2011-07-12 2016-01-20 上海医药工业研究院 4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用
WO2013024164A1 (en) 2011-08-18 2013-02-21 Shire Ag Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
EP3413891B1 (en) * 2016-02-11 2024-01-03 Symed Labs Limited Processes for the preparation of highly pure prucalopride succinate
CN110963999B (zh) * 2019-11-27 2021-05-11 广东东阳光药业有限公司 2,3-二氢苯并呋喃酰胺衍生物及其用途

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2396757A2 (fr) * 1977-07-08 1979-02-02 Ile De France Nouveaux 2,3-alkylene bis (oxy) benzamides substitues, leurs derives et leurs procedes de preparation
FR2493848B2 (fr) * 1980-11-07 1986-05-16 Delalande Sa Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
EP0069481A1 (en) * 1981-06-17 1983-01-12 Beecham Group Plc Azabicycloalkyl benzamides, process for their preparation and pharmaceutical compositions containing them
EP0068700A1 (en) * 1981-06-29 1983-01-05 Beecham Group Plc Azobicycloalkylbenzamides, process for their preparation and pharmaceutical compositions containing them
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
CA1183847A (en) 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
AU563225B2 (en) * 1982-04-14 1987-07-02 Alizyme Therapeutics Limited I-aza bicyclic compounds
EP0108986A1 (en) * 1982-11-02 1984-05-23 Hokuriku Pharmaceutical Co.,Ltd N-substituted flavone-8-carboxamides
EP0135545A1 (en) * 1983-02-19 1985-04-03 Beecham Group Plc Azabicycloalkyl benzamide and anilide derivatives
JPS59186969A (ja) * 1983-04-08 1984-10-23 Yoshitomi Pharmaceut Ind Ltd ベンゾフラン−およびベンゾピランカルボキサミド誘導体
CA1297877C (en) * 1983-12-22 1992-03-24 Daniel Lednicer Benzofurancarboxamides useful as antiemetic or antipsychotic agents
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
GB8527052D0 (en) * 1985-11-02 1985-12-04 Beecham Group Plc Compounds
FR2593504B1 (fr) 1986-01-30 1988-12-09 Ile De France Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
US4906643A (en) * 1987-07-17 1990-03-06 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides as gastrointestinal agents
US5130312A (en) * 1987-07-17 1992-07-14 Janssen Pharmaceutica N.V. Substituted N-(3-hydroxy-4-piperidinyl)benzamides
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
GB8718346D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa Substituted benzamides
ZA886585B (en) * 1987-09-08 1990-05-30 Lilly Co Eli Specific 5-ht,antagonists
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5041454A (en) * 1987-09-25 1991-08-20 Janssen Pharmaceutica N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US4975439A (en) * 1987-09-25 1990-12-04 Janssen Pharmaceutical N.V. Novel substituted N-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US4863921A (en) * 1988-04-27 1989-09-05 Rorer Pharmaceutical Corporation Dibenzofurancarboxamides and their pharmaceutical compositions and methods
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives

Also Published As

Publication number Publication date
IE910710A1 (en) 1991-09-11
HRP930483A2 (en) 1995-12-31
SK282406B6 (sk) 2002-01-07
PL168384B1 (en) 1996-02-29
ZW2391A1 (en) 1992-09-07
HRP930483B1 (en) 2001-04-30
ZA911611B (en) 1992-11-25
EP0445862B1 (en) 2000-04-19
UA25969A1 (uk) 1999-02-26
IL97018A (en) 1995-11-27
NO177424B (no) 1995-06-06
MA22076A1 (fr) 1991-10-01
PL168811B1 (pl) 1996-04-30
HU211350A9 (en) 1995-11-28
LV10085B (en) 1995-02-20
PL168356B1 (pl) 1996-02-29
TNSN91010A1 (fr) 1992-10-25
JPH04211685A (ja) 1992-08-03
SG47482A1 (en) 1998-04-17
PT96937B (pt) 1998-07-31
LT3708B (en) 1996-02-26
CA2037575A1 (en) 1991-09-07
LTIP846A (en) 1995-02-27
BG60381B1 (bg) 1995-01-31
PL289323A1 (en) 1992-03-09
CN1038936C (zh) 1998-07-01
NO910863L (no) 1991-09-09
CA2037575C (en) 2003-09-16
YU39691A (sh) 1994-06-10
SK282407B6 (sk) 2002-01-07
US5185335A (en) 1993-02-09
PT96937A (pt) 1991-10-31
KR0177521B1 (ko) 1999-03-20
RU2070884C1 (ru) 1996-12-27
EP0445862A2 (en) 1991-09-11
AU7207991A (en) 1991-09-12
ATE191912T1 (de) 2000-05-15
FI911096A0 (fi) 1991-03-05
CS46091A3 (en) 1991-10-15
CY2235B1 (en) 2003-07-04
SI9110396B (sl) 2000-06-30
HU910706D0 (en) 1991-09-30
FI101622B (fi) 1998-07-31
YU48854B (sh) 2002-06-19
MY108831A (en) 1996-11-30
AU636012B2 (en) 1993-04-08
DK0445862T3 (da) 2000-09-04
NZ237189A (en) 1992-11-25
US5262418A (en) 1993-11-16
JP2601566B2 (ja) 1997-04-16
LV10085A (lv) 1994-05-10
DE69132119D1 (de) 2000-05-25
CZ286617B6 (cs) 2000-05-17
HUT60733A (en) 1992-10-28
GR3033461T3 (en) 2000-09-29
IL97018A0 (en) 1992-03-29
HK1010727A1 (en) 1999-06-25
ES2147175T3 (es) 2000-09-01
DE69132119T2 (de) 2000-12-21
HU221627B1 (hu) 2002-12-28
EP0445862A3 (en) 1992-05-20
SI9110396A (en) 1997-12-31
GB9005014D0 (en) 1990-05-02
FI101622B1 (fi) 1998-07-31
PL169238B1 (pl) 1996-06-28
NO177424C (no) 1995-09-13
PL168693B1 (pl) 1996-03-29
KR910016744A (ko) 1991-11-05
NO910863D0 (no) 1991-03-05
PL168686B1 (pl) 1996-03-29
FI911096A (fi) 1991-09-07
CN1054598A (zh) 1991-09-18

Similar Documents

Publication Publication Date Title
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
MY129970A (en) Hypolipidaemic compounds
DE3762618D1 (de) Amidderivate.
SE9203825L (sv) Dubbelt verkande inhibitorer foer no-syntas och cyklooxygenas, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
RU94038064A (ru) Производные пиперазина и пиперидина, их применение в качестве противопсихотических средств, способ их получения фармацевтическая композиция
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
MY136686A (en) Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of production
DK162883D0 (da) N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme
DK0892794T3 (da) Acylerede N-hydroxymethyl thalidomid-promedikamenter med immunmodulatorisk virkning
ATE268337T1 (de) C11-carbamate von antibakteriellen makroliden
DK0573318T3 (da) 4-phenylcarbamoyl-3-isoxazolcarboxylsyreforbindelser, fremgangsmåde til deres fremstilling, farmaceutiske præparater med in
FI834800A0 (fi) Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat
EA200001029A1 (ru) Производные гигромицина
DK0643061T3 (da) Nye cephalosporin-antibitotika
DE69217717D1 (de) Benzopyranderivate und Verfahren zu deren Herstellung
ES499915A1 (es) Procedimiento para la obtencion de derivados del aminotia- diazolilo
ATE222583T1 (de) Derivate substituierter amidinonaphthylester
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.
EA200100677A1 (ru) Производные 6-азаурацила, ингибирующие il-5
RU95108539A (ru) Производные пенема, их получение и содержащая их фармацевтическая композиция
YU196891A (sh) Derivati tioacid amida i krmni preparati koji sadrže iste
ES478502A1 (es) Un procedimiento para la preparacion de nuevas n-(piridotie-nopirazol)amidas